OpenVSafe by OpenVAERS
Search V-safe

2QL-98629-66506

3 vaccinations 2 coded responses 17 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
730 / OK
Registered
2021-01-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-06
    Registered in v-safe
  3. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  5. 2021-01-25
    Survey response — day 14, dose 2
    MedDRA: Headache, Malaise — Feeling: Good · Be unable to work
    Free text: In the 24 hours post second dose I had a headache for about 15 hours which started about 12 hours post injection. The day following the second dose I had genera malaise. All notes symptoms were gone less than 48 hours post 2nd dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-02-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-12-02
    Dose 3 — Pfizer-BioNTech
  13. 2021-12-15
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  14. 2021-12-16
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-12-23
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  16. 2021-12-30
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-01-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-01-15
    Survey response — day 42, dose 3
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: Cold like symptoms
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-03-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  20. 2022-06-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  21. 2022-12-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech
32021-12-02Pfizer-BioNTech No

Free text

Release 2 — day 14, dose 2

2021-01-25

Symptoms: In the 24 hours post second dose I had a headache for about 15 hours which started about 12 hours post injection. The day following the second dose I had genera malaise. All notes symptoms were gone less than 48 hours post 2nd dose.

Release 10 — day 42, dose 3

2022-01-15

Symptoms: Cold like symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache ✓ ✓ ✓
SDMalaise ✓ ✓ ✓
SDNasopharyngitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…